Chenyu Lin
Assistant Professor of MedicineOverview
Medical Director, Cellular Therapy Program
Hematologic oncologist specializing in the care of patients with acute leukemias and aggressive lymphomas, and those patients who require administration of an immune effector cellular therapy. Dr. Lin oversees Duke's cellular therapy program, which provides cell-based treatments such as chimeric antigen receptor T (CAR T) cell therapy and tumor infiltration lymphocytes (TILs) for a wide variety of cancers and autoimmune disorders. His research interests include in clinical trials, digital health, and real-world evidence.
Fellowship: Duke Cancer Institute
Residency: Northwestern University
Medical School: University of Chicago Pritzker School of Medicine
Undergraduate: Yale University
Positions
Assistant Professor of Medicine in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2023 School of Medicine
Education
M.D., The University of Chicago 2016
2016 The University of Chicago
Resident, Northwestern University, INTERNAL MEDICINE 2016 - 2019
2019 Northwestern University
Hospitalist, Northwestern University 2019 - 2020
2020 Northwestern University
Clinical Trials
Publications, Grants & Awards
- Grants (6)
- Awards (11)
- Academics Articles (22)
- Conference Pages (11)
Rigel Pharmaceuticals, Inc.
Incyte Corporation
Blue Spark Technologies, Inc.
University of North Carolina - Chapel Hill